ArticleCancers2021
Reduction in Standard Cancer Screening in 2020 throughout the U.S.
Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- Pooled it
- Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care.Preventive medicine · 2022Pooled it
- The Impact of the COVID-19 Pandemic on Breast and Cervical Cancer Screening: A Systematic Review.In vivo (Athens, Greece)Pooled it
- Prevalence of preventive cancer screening in skin cancer survivors is greater compared to non-cancer individuals: a retrospective cross-sectional analysis.International journal of women's dermatology · 2026Article
- Provider and Organizational Factors Impacting Routine Cancer Screening Among Older Medicaid Enrollees.Health services research · 2026Article
- The impact of the pandemic on non-COVID-19 causes of death in the United States: a multiple cause of death analysis.European journal of epidemiology · 2025Article
- Disparities in Cancer Stage Shifts Associated with the COVID-19 Pandemic in California, 2020 to 2021.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025Article
- Socioeconomic determinants of cancer screening adherence among cancer survivors: analysis from the 2020 Behavioral Risk Factor Surveillance System.JNCI cancer spectrum · 2025Article
- Colorectal cancer screening participation in First Nations populations worldwide: a systematic review and data synthesis.EClinicalMedicine · 2024Article
- Article
- Colorectal Screening During the COVID-19 Pandemic: Delayed but Not Forgotten.Digestive diseases and sciences · 2023Article
- Cervical Cancer Knowledge and Screening Patterns in Zuni Pueblo Women in the Southwest United States.Journal of cancer education : the official journal of the American Association for Cancer Education · 2023Article
- The 2020 US cancer screening deficit and the timing of adults' most recent screen: a population-based cross-sectional study.Family medicine and community health · 2023Article
- Article
- Impact of the COVID-19 pandemic on the breast cancer early diagnosis program in Brazil.Preventive medicine reports · 2023Article
- Barriers driving health care disparities in utilization of age-appropriate screening.Frontiers in public health · 2023Article
- The Impact of COVID-19 Infection in Cancer 2020-2021.Cancers · 2022Article
- Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System.Healthcare (Basel, Switzerland) · 2022Article
- Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions.Medicina (Kaunas, Lithuania) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer screening is an important way to reduce the burden of cancer. The COVID-19 pandemic created delays in screening with the potential to increase cancer disparities in the United States (U.S.). Data from the 2014-2020 Behavioral Risk Factor Surveillance System (BRFSS) survey were analyzed to estimate the percentages of adults who reported cancer screening in the last 12 months consistent with the U.S. Preventive Services Task Force (USPSTF) recommendation for cervical (ages 21-65), breast (ages 50-74), and colorectal cancer (ages 50-75) prior to the pandemic. Cancer screening percentages for 2020 (April-December excluding January-March) were compared to screening percentages for 2014-2019 to begin to look at the impact of the COVID-19 pandemic. Screening percentages for 2020 were decreased from those for 2014-2019 including several underserved racial groups. Decreases in mammography and colonoscopy or sigmoidoscopy were higher among American Indian/Alaskan Natives, Hispanics, and multiracial participants, but decreases in pap test were also highest among Hispanics, Whites, Asians, and African-Americans/Blacks. Decreases in mammograms among women ages 40-49 were also seen. As the 2020 comparison is conservative, the 2021 decreases in cancer screening are expected to be much greater and are likely to increase cancer disparities substantially.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.